Respiratory care specialist Vapotherm raised $56 million in an initial public offering of 4 million shares, priced at the low end of the range at $14. The Exeter, New Hampshire-based company plans to ...

Vapotherm’s Precision Flow Hi-VNI system provides more precise control over the amount of oxygen being delivered to patients than conventional HFNC systems, as the Vapotherm Precision Flow Hi-VNI ...

Infinium Medical, through its Infinium Veterinary division will be exclusively distributing Vapotherm VET 2.0 high-velocity respiratory therapy systems. This partnership allows us to provide ...

Joe Army, Vapotherm's President and Chief Executive Officer expressed his optimism, stating, "I'm excited about emerging market growth for Vapotherm. In the third quarter of 2023, we posted 25% global ...

Children, as well as their parents, may one day be able to breathe a little easier: The respiratory therapy company Vapotherm said a pilot study of its high-flow treatment showed it could outperform ...

Vapotherm, Inc., a developer and manufacturer of advanced respiratory technology, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its All Patient ...

NEW YORK, Dec. 15, 2023 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCM) (OTCQX: OTCM), operator of regulated markets for 12,000 U.S. and international securities, today announced Vapotherm, Inc.

Increased capacity anticipated to scale capital production by up to 20X above pre-COVID-19 pandemic levels At maximum capacity, increased production could create up to 350 manufacturing jobs in New ...

EXETER, N.H., Feb. 29, 2024 /PRNewswire/ -- Vapotherm, Inc. (OTCQX: VAPO), ("Vapotherm" or the "Company"), a global medical technology company specializing in the development and commercialization of ...

Vapotherm’s Precision Flow Hi-VNI system provides more precise control over the amount of oxygen being delivered to patients than conventional HFNC systems, as the Vapotherm Precision Flow Hi-VNI ...